Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Emcure Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:544210NSE Symbol: EMCUREP/E(TTM):76.72
ISIN Demat:INE168P01015Div & Yield %:0.23EPS(TTM):16.73
Book Value(Rs):159.5913001Market Cap ( Cr.):24324.34Face Value(Rs):10
    Change Company 
Whole Time DirectorMUKUND KESHAO GURJAR
SUNIL RAJNIKANT MEHTA
Managing Director & CEOSATISH RAMANLAL MEHTA
Chairman & Independent DirectoBerjis M Desai
Whole Time DirectorNAMITA VIKAS THAPAR
Independent DirectorP S Jayakumar
Vijay Gokhale
Vidya Rajiv Yeravdekar
Non Executive DirectorSamonnoi Banerjee
Independent DirectorShailesh Ayyangar
Whole-time DirectorSAMIT SATISH MEHTA
Company Sec. & Compli. OfficerCHETAN RAJENDRA SHARMA